Ebru K. Bish

Ebru K. Bish

Auto-generated profile, based on publicly available information

Ebru K. Bish

Information Systems, Statistics, & Management Science, Culverhouse College of Business, The University of Alabama, Tuscaloosa, AL, USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2007 in Naval Research Logistics (NRL)
Verified
Journal Article
Closed access
PDF file
BMBacel Maddah
Bacel Maddah
EBEbru K. Bish
Ebru K. Bish

6 August 2019 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
NNNgoc T. Nguyen
Ngoc T. Nguyen
HAHrayer Aprahamian
Hrayer Aprahamian
EBEbru K. Bish
Ebru K. Bish
DBDouglas R. Bish
Douglas R. Bish
Pooled testing, in which biological specimens from multiple subjects are combined into a testing pool and tested via a single test, is a common testing method for both surveillance and screening activities. The sensitivity of pooled testing for various pool sizes is an essential input for surveillance and screening optimization, including testing pool design. However, clinical data on test sensitivity values for different pool sizes are limited, and do not provide a functional relationship between test sensitivity and pool size. We develop a novel methodology to accurately compute the sensitivity of pooled testing, while accounting for viral load progression and pooling dilution. We demonstrate our methodology on the nucleic acid amplification testing (NAT) technology for the human immunodeficiency virus (HIV). Our methodology integrates mathematical models of viral load progression and pooling dilution to derive test sensitivity values for various pool sizes. This methodology derives the conditional test sensitivity, conditioned on the number of infected specimens in a pool, and uses the law of total probability, along with higher dimensional integrals, to derive pooled test sensitivity values. We also develop a highly accurate and easy-to-compute approximation function for pooled test sensitivity of the HIV ULTRIO Plus NAT Assay. We calibrate model parameters using published efficacy data for the HIV ULTRIO Plus NAT Assay, and clinical data on viral RNA load progression in HIV-infected patients, and use this methodology to derive and validate the sensitivity of the HIV ULTRIO Plus Assay for various pool sizes. We demonstrate the value of this methodology through optimal testing pool design for HIV prevalence estimation in Sub-Saharan Africa. This case study indicates that the optimal testing pool design is highly efficient, and outperforms a benchmark pool design. The proposed methodology accounts for both viral load progression and pooling dilution, and is computationally tractable. We calibrate this model for the HIV ULTRIO Plus NAT Assay, show that it provides highly accurate sensitivity estimates for various pool sizes, and, thus, yields efficient testing pool design for HIV prevalence estimation. Our model is generic, and can be calibrated for other infections.

1 February 2018 in Operations Research
Verified
Journal Article
Closed access
HEHadi El-Amine
Hadi El-Amine
EBEbru K. Bish
Ebru K. Bish
DBDouglas R. Bish
Douglas R. Bish
Blood products are essential components of any healthcare system, and their safety, in terms of being free of transfusion-transmittable infections, is crucial. While the Food and Drug Administration (FDA) in the United States requires all blood donations to be tested for certain infection types, it does not dictate which particular tests should be used by blood centers. Multiple FDA-licensed blood screening tests are available for each infection type, and screening tests are imperfectly reliable and have different costs. In addition, infection prevalence rates within the donor population are uncertain for both emerging and established infection types. In this setting, the budget-constrained blood center’s objective is to devise a “robust” postdonation bloodscreening scheme that minimizes the risk of an infectious donation being released into the blood supply. Toward this goal, we study the minimization of the transfusion-transmittable infection risk considering regret- and expectation-based objectives, and we characterize structural properties of their optimal solutions. This allows us to gain insight, derive the price of robustness, and develop efficient algorithms. The proposed robust solution lowers the expected infection risk over various FDA-compliant testing schemes as well as the expectation-based scheme under forecast error. These findings have important public policy implications. The e-companion is available at https://doi.org/10.1287/opre.2017.1658 .

16 March 2021 in Naval Research Logistics (NRL)
Verified
Journal Article
Closed access
PDF file
HHHussein El Hajj
Hussein El Hajj
DBDouglas R. Bish
Douglas R. Bish
EBEbru K. Bish
Ebru K. Bish
HAHrayer Aprahamian
Hrayer Aprahamian

10 April 2018 in IISE Transactions
Verified
Journal Article
Open access
HAHrayer Aprahamian
Hrayer Aprahamian
EBEbru K. Bish
Ebru K. Bish
DBDouglas R. Bish
Douglas R. Bish
Pooled testing is commonly used in public health screening for classifying subjects in a large population as positive or negative for an infectious or genetic disease. Pooling is especially useful when screening for low-prevalence diseases under limited resources. Although pooled testing is used in various contexts (e.g., screening donated blood or for sexually transmitted diseases), a lack of understanding of how an optimal pooling scheme should be designed to maximize classification accuracy under a budget constraint hampers screening efforts. We propose and study an adaptive risk–based pooling scheme that considers important test and population level characteristics often over looked in the literature (e.g., dilution of pooling and heterogeneous subjects). We characterize important structural properties of optimal subject assignment policies (i.e., assignment of subjects, with different risk, to pools) and provide key insights. Our case study, on chlamydia screening, demonstrates the effectiveness of the proposed pooling scheme, with the expected number of false classifications reduced substantially over policies proposed in the literature.

7 June 2004 in Naval Research Logistics (NRL)
Verified
Journal Article
Closed access
PDF file
EBEbru K. Bish
Ebru K. Bish
RSRawee Suwandechochai
Rawee Suwandechochai
DBDouglas R. Bish
Douglas R. Bish